PRCT.US Procept Biorobotics Corp

Healthcare Health Care Equipment & Supplies USA Stocks
23.54 USD
Close of Nov 17, 2026
16.67 38.11
Market cap
USD 1.35B
P/E
-
P/B
4.17x
ROE
-34.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PRCT.US undervalued?

Graham number

The Graham number of Procept Biorobotics Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Procept Biorobotics Corp fundamental analysis

No fundamental analysis for Procept Biorobotics Corp yet.

Procept Biorobotics Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Procept Biorobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males s…

Full company profile